Literature DB >> 8475411

Drug resistance modulation in the laboratory and the clinic.

W S Dalton1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8475411

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

Review 1.  Overcoming drug resistance in ovarian carcinoma.

Authors:  P M Fracasso
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

2.  Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.

Authors:  L Kabasakal; K Ozker; M Hayward; G Akansel; O Griffith; A T Isitman; R Hellman; D Collier
Journal:  Eur J Nucl Med       Date:  1996-05

3.  Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival.

Authors:  H Yokoyama; T Ishida; K Sugio; T Inoue; K Sugimachi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.